Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

241.17
Delayed Data
As of Jul 02
 +3.94 / +1.66%
Today’s Change
128.50
Today|||52-Week Range
349.08
+54.60%
Year-to-Date

Today’s Trading

Previous close237.23
Today’s open236.13
Day’s range236.00 - 242.56
Volume212,543
Average volume (3 months)492,122
Market cap$5.8B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+34.86%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book22.39

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc-1.36-0.69%
IDXXIDEXX Laboratories I...-0.73-1.16%
SGENSeattle Genetics Inc-0.17-0.36%
TAROTaro Pharmaceutical ...+0.16+0.11%
Data as of 4:07pm ET, 07/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$2.00
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers